A potential new option is beginning to emerge for patients with the fastest growing form of cancer in the United States, according to researchers at the University of Alabama at Birmingham.... Read more
A new study supports the use of a DNA-based “biomarker” blood test as a complement to the prostate-specific antigen (PSA) test currently offered to screen men for prostate cancer... Read more
